Passa al contenuto
Merck
  • Altered pulmonary artery endothelial-smooth muscle cell interactions in experimental congenital diaphragmatic hernia.

Altered pulmonary artery endothelial-smooth muscle cell interactions in experimental congenital diaphragmatic hernia.

Pediatric research (2015-01-13)
Shannon N Acker, Gregory J Seedorf, Steven H Abman, Eva Nozik-Grayck, Katherine Kuhn, David A Partrick, Jason Gien
ABSTRACT

Pulmonary hypertension (PH) secondary to vascular remodeling contributes to poor outcomes in congenital diaphragmatic hernia (CDH), however mechanisms responsible are unknown. We hypothesized that pulmonary artery endothelial cell (PAEC) dysfunction contributes to smooth muscle cell (SMC) hyperplasia in experimental CDH. PAEC and SMC were isolated from fetal sheep with experimental CDH and controls. SMC growth was assessed alone and with SOD plus catalase and during coculture with control or CDH PAEC with and without ET-1 siRNA transfection. ET-1 protein was measured in PAEC and SMC lysates and supernatant. ROS production was measured in normal and CDH PAECs with and without ET-1 siRNA. PAEC growth and tube formation were measured with SOD plus catalase. CDH SMC growth was decreased and increased with coculture with CDH PAEC more than control PAEC. Treatment of CDH PAEC with SOD plus catalase or ET-1 siRNA prevented the increase in SMC growth seen with coculture. ET-1 protein was increased in CDH PAEC and SMC. ROS production was increased in CDH PAEC and decreased with ET-1 SiRNA. SOD plus catalase restored CDH PAEC growth and tube formation. PAEC dysfunction in experimental CDH increases SMC proliferation via ET-1 induced ROS production by PAEC.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Perossido di idrogeno, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Perossido di idrogeno, 50 wt. % in H2O, stabilized
Sigma-Aldrich
Perossido di idrogeno, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur.
Sigma-Aldrich
Endothelin 1, ≥97% (HPLC), powder
Sigma-Aldrich
Ethanolamine, ≥99%
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 35 wt. % in H2O
Sigma-Aldrich
Perossido di idrogeno, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Sigma-Aldrich
Ethanolamine, purified by redistillation, ≥99.5%
Sigma-Aldrich
Perossido di idrogeno, purum p.a., ≥35% (RT)
Sigma-Aldrich
Ethanolamine, ≥98%
Millipore
Perossido di idrogeno, 3%, suitable for microbiology
Sigma-Aldrich
Ethanolamine, ACS reagent, ≥99.0%
Sigma-Aldrich
Perossido di idrogeno, 34.5-36.5%
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Supelco
Perossido di idrogeno, ≥30%, for trace analysis
Supelco
Perossido di idrogeno, 30 % (w/w), for ultratrace analysis
Sigma-Aldrich
Ethanolamine, liquid, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
Acido bicinconinico, ≥98% (HPLC)
Sigma-Aldrich
Perossido di idrogeno, tested according to Ph. Eur.
Supelco
Ethanolamine, analytical standard
Supelco
Aucubin, analytical standard
Sigma-Aldrich
Ethanolamine, puriss. p.a., ACS reagent, ≥99.0% (GC/NT)
Trolamine impurity A, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting human EDN1
Aucubin, primary reference standard